MedTrace Logo

The Role of Lactobacillus Reuteri in Children and Adolescents With Anorexia Nervosa

NCT02004288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2021-06-23

Study results available
· View outcomes & findings →

Summary

The aim of this study is to investigate whether Lactobacillus reuteri could have a beneficial role in treatment of children and adolescents with Anorexia nervosa who develop motility disorder due to the malnutrition regarding the normalization of the motility, as well as the possible role of probiotics on nutritional recovery, especially on bone health.

Conditions

Interventions

DIETARY_SUPPLEMENT

Lactobacillus reuteri Protectis DSM17938

One chewable tablet with L. reuteri or placebo taken twice a day for 3 months. After the 3 month therapy both groups will be monitored for the next 3 months.

Sponsors & Collaborators

  • BioGaia AB

    lead INDUSTRY

Principal Investigators

  • Orjena Zaja Franulovic, MD, PhD · Center for Eating disorders Sestre milosrdnice University hospital Zagreb, Croatia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02004288 on ClinicalTrials.gov